Refractory Germ-cell
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors (NCT03333616) | Dana-Farber Cancer Institute | 2017-12-28 |
Track Refractory Germ-cell automatically
Every clearance here is in the API, with alerts when new ones post.